Rehmann Capital Advisory Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-534
| Closed | -$45.1K | – | 1976 |
|
|
2019
Q2 | $45.1K | Sell |
534
-4
| -0.7% | -$338 | 0.01% | 872 |
|
|
2019
Q1 | $47.4K | Sell |
538
-10
| -2% | -$881 | 0.01% | 827 |
|
|
2018
Q4 | $39.1K | Sell |
548
-9
| -2% | -$643 | 0.01% | 666 |
|
|
2018
Q3 | $68.5K | Buy |
557
+197
| +55% | +$24.2K | 0.01% | 695 |
|
|
2018
Q2 | $35.4K | Buy |
360
+14
| +4% | +$1.38K | 0.01% | 903 |
|
|
2018
Q1 | $29K | Buy |
+346
| New | +$29K | ﹤0.01% | 956 |
|